(514) 393-1055

Chemical Computing Group Unveils New Scalable Multi-processorTechnology for Life Science Researchers

Montreal, Canada; Boulder, Colorado, April 9, 2002

HP systems used to develop technology

Chemical Computing Group Inc. (CCG) unveiled its new scalable multi-processor technology (MOE/smp) today at the Spring National Meeting of the American Chemical Society. Developed on systems from Hewlett-Packard Company, MOE/smp will provide life science researchers with the ability to run on multi-computer proce

Terry Higgins, Director of Research & Development for CCG, said "One of the high points of the new release of MOE version 2002.03 is the ability for life science researchers to run calculation intensive MOE applications on either a real cluster box and/or a virtual cluster. The virtual cluster is made up of available CPUs that chemists have access to on their network. The virtual cluster can be a combination of any of the platforms MOE supports (Windows, Linux, Unix) thus maximizing their use of available resources."

"To develop, test and validate this new hybrid technology," Higgins went on to say, "CCG turned to HP. We have been an HP partner for the past three years utilizing their Windows, Linux and Unix (HP-UX) based workstations to develop our leading Bioinformatics, Cheminformatics and Molecular Modeling applications. We have been very pleased with their dependability, technological expertise and advanced systems so they were a natural choice when we began the MOE/smp project."

"HP was pleased to be chosen by CCG as the development platform for this new exciting technology," said David Valenta, Global Market Development Manager, HP Life Sciences. "By providing life science researchers with access to more CPU power, CCG's MOE/smp helps speed up computational time and hence the time from idea to discovery. We feel this new MOE capability will be a major paradigm shift on how computational groups use their resources."

MOE version 2002.03 is slated to be shipped to CCG's worldwide customer base at the end of April and will include, in addition to the MOE/smp architecture, new capabilities in the areas of:

  • Integrated sequence and structural protein fold/homology detection;
  • Structural prediction of protein amino-acid mutations;
  • High throughput conformational analysis
  • High speed 3D pharmacophore analysis and search
For more information, please visit our web page: http://www.chemcomp.com
For more information about HP Life Sciences, please visit http://www.hp.c../lifesciences


Chemical Computing Group (http://www.chemcomp.com) develops and markets MOE, the Molecular Operating Environment, a leading application for chemical researchers in the pharmaceutical and biotechnology fields. MOE's built-in applications cover the spectrum of drug discovery including: Protein/Homology Modeling, High Throughput Screening, Combinatorial Library Design, Modeling/Simulations and Methods Development. MOE's unique architecture and platform independence allows it to be used enterprise-wide by a variety of researchers from methods developers to computational experts and medicinal chemists. Its customers include a worldwide roster of leading pharmaceutical and biotechnology companies.